Navigating regulatory challenges for cell and gene therapy products in 2024 and beyond
1:10:06
Cell & Gene Therapy Products 2022 Keynote: Peter Marks, CBER, FDA
2:08:30
Dec 2024-Day 2, Introductions, Session 2 Talks, Panel Discussion
54:05
Understanding the New Returns and Exceptions Process
36:14
OIS Podcast Ep #381: Approachable Regenerative Medicine
55:21
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
1:01:14
Clinical Trials Overview: Phrases and Phases of a Clinical Trials
59:51
A-Gene: Regulatory Considerations
57:06